Solmetex v. Dental Recycling North America — Dismissed With Prejudice After 364 Days
Solmetex, LLC brought a patent infringement action against Dental Recycling North America, Inc. in the District of Delaware, asserting US11660175B2 covering a detachable recycling container. After 364 days of litigation, both parties stipulated to dismiss all claims and counterclaims with prejudice, each bearing their own costs and attorneys’ fees.
Dental recycling patent dispute ends in mutual dismissal with prejudice
Solmetex, LLC filed suit against Dental Recycling North America, Inc. (DRNA) on June 1, 2023, in the United States District Court for the District of Delaware before Judge Maryellen Noreika. The infringement action centred on US11660175B2, a patent covering a detachable recycling container — a product category directly relevant to dental amalgam waste management. Solmetex is an established player in dental waste compliance solutions and asserted the patent against DRNA, a competing recycling services provider in the dental sector.
The case closed on May 30, 2024, via a Rule 41(a)(1)(A)(ii) stipulated dismissal signed by both parties. Critically, both Solmetex’s infringement claims against DRNA and DRNA’s counterclaims against Solmetex were dismissed with prejudice. A with-prejudice dismissal is a final adjudication on the merits as a matter of law, meaning neither party may relitigate the same claims in any future proceeding. The parties agreed to bear their own costs and attorneys’ fees, suggesting no financial concession was extracted by either side as part of the resolution.
The 364-day duration suggests the case progressed through early-stage litigation — likely pleadings, initial discovery, and potentially claim construction preparation — before the parties reached a resolution. The mutual nature of the dismissal, covering both claims and counterclaims, is consistent with a negotiated settlement or cross-licensing arrangement, though the public record contains no disclosure of commercial terms. What drove DRNA to bring counterclaims, and what ultimately precipitated the mutual exit, remains unknown from available filings.
Filing to Dismissed with Prejudice in 364 days
364 days — slightly under the median time-to-resolution for single-patent infringement cases in Delaware District Court
Dismissed with prejudice: what the stipulated exit means for both parties
Rule 41(a)(1)(A)(ii) — stipulated dismissal with prejudice
A Rule 41(a)(1)(A)(ii) dismissal is filed by agreement of all parties, requiring no court order. The ‘with prejudice’ designation converts it into a final judgment on the merits by operation of law. This forecloses either party from refiling the same claims in any US federal court. It is the most legally conclusive form of voluntary exit from litigation short of a full trial verdict.
Res judicata appliesSolmetex forfeits future infringement claims on the same conduct
By agreeing to dismiss with prejudice, Solmetex permanently surrenders its right to pursue DRNA for the specific infringement conduct alleged in this action. While Solmetex retains ownership of US11660175B2 and may enforce it against other parties, any future action against DRNA for the same accused product or conduct would face a strong res judicata bar. The no-costs arrangement means Solmetex received no fee award for bringing the suit.
Patent remains enforceable vs. othersDRNA’s counterclaims also extinguished — a double-edged result
DRNA’s counterclaims — the nature of which is not fully disclosed in public filings — were likewise dismissed with prejudice. This is notable: if DRNA had asserted invalidity of US11660175B2 as a counterclaim, that challenge is now gone. DRNA cannot later seek to invalidate the patent through the same counterclaim theory. This outcome may reflect a negotiated trade-off: freedom to operate in exchange for dropping the invalidity challenge.
Counterclaim invalidity challenge droppedSettlement signals competitive détente in dental recycling market
The mutual dismissal with each party bearing its own costs is consistent with a negotiated commercial resolution — potentially a licence, cross-licence, or market-sharing arrangement — though no terms are public. For competitors in the dental waste recycling space, US11660175B2 remains an active, enforceable patent. The survival of the patent without a successful invalidity challenge means third parties cannot rely on DRNA’s dropped counterclaim to clear the IP landscape.
US11660175B2 remains live IP riskFull party and counsel information
| Role | Name | Type | Detail |
|---|---|---|---|
| Plaintiff | Solmetex, LLC | Company | Dental waste compliance solutions provider — holder of US11660175B2Search in Eureka ↗ |
| Defendant | Dental Recycling North America, Inc. | Company | Dental Recycling North America, Inc. — dental amalgam recycling services competitorSearch in Eureka ↗ |
| Plaintiff counsel | Allison E. Strong | Attorney | Counsel for Solmetex, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Andrew Colin Mayo | Attorney | Counsel for Solmetex, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Angelo J. Christopher | Attorney | Counsel for Solmetex, LLCSearch in Eureka ↗ |
| Plaintiff counsel | Daniel J. Burnham | Attorney | Counsel for Solmetex, LLCSearch in Eureka ↗ |
| Plaintiff law firm | Ashby & Geddes PC | Law Firm | Representing Solmetex, LLCSearch in Eureka ↗ |
| Defendant counsel | Andrew Gish | Attorney | Counsel for Dental Recycling North America, Inc.Search in Eureka ↗ |
| Defendant counsel | David Ellis Moore | Attorney | Counsel for Dental Recycling North America, Inc.Search in Eureka ↗ |
| Defendant counsel | Michael Powell | Attorney | Counsel for Dental Recycling North America, Inc.Search in Eureka ↗ |
| Defendant counsel | Ryan K. Iwahashi | Attorney | Counsel for Dental Recycling North America, Inc.Search in Eureka ↗ |
| Defendant law firm | Potter, Anderson & Corroon LLP | Law Firm | Representing Dental Recycling North America, Inc.Search in Eureka ↗ |
| Presiding judge | Judge Maryellen Noreika | Judge | Delaware District CourtSearch in Eureka ↗ |
Official order — verbatim text
The stipulated dismissal language is precise and bilateral: Solmetex’s infringement claims and DRNA’s counterclaims are each extinguished with prejudice. The phrasing ‘pursuant to Rule 41(a)(1)(A)(ii)’ confirms this required no judicial intervention — it is a binding contractual resolution between the parties. The equal cost allocation clause (‘shall each bear their own costs’) is a deliberate drafting choice that avoids any implication of a prevailing party, which has implications for any future fee-shifting arguments. No merits determination was made by the court.
US11660175B2 — Detachable dental amalgam recycling container
US11660175B2 (application number US17/965556) covers a detachable recycling container, a product category central to dental office compliance with EPA amalgam rule requirements. The patent’s application context places it squarely in the dental waste management sector, where proper collection and recycling of mercury-containing amalgam is a regulatory mandate. The ‘B2’ grant designation indicates the patent has already survived the examination process with claims confirmed, giving it a presumption of validity under 35 U.S.C. § 282.
In a market where dental amalgam separators and recycling containers are mandated by EPA regulations for most dental practices, IP protection over container design and detachability mechanisms can confer durable competitive advantage. Solmetex is a recognised compliance solutions brand in this space, and a patent on detachable container architecture could restrict competitors from offering functionally equivalent recycling products. With DRNA’s invalidity counterclaim now dismissed with prejudice, the patent faces a narrower near-term challenge profile — though IPR proceedings at the USPTO remain a separate avenue for challenge.
Should your team run an FTO against US11660175B2?
Any company developing, manufacturing, or distributing detachable recycling containers for dental amalgam waste — or designing separator systems with modular or swappable collection chambers — should assess freedom to operate against US11660175B2. The patent survived this litigation without any court-ordered claim construction, meaning the enforceable scope of its claims remains untested and potentially broad. Dental equipment OEMs, waste management services, and compliance product distributors entering this category face real infringement exposure.
PatSnap Eureka’s FTO Search Agent can map the claim language of US11660175B2 against your product specifications and flag design-around risk with citation-level precision. Eureka’s prior art canvas can also surface references that were not raised in the DRNA counterclaim — giving your IP team a starting point for a future IPR petition or defensive design-around strategy. Run the FTO before your next product launch in dental waste compliance.
Run a freedom-to-operate analysis on US11660175B2 to assess your product’s exposure
Run FTO in Eureka →Similar dental and medical device patent cases in Delaware District Court
Related infringement actions involving dental and medical waste device patents in the District of Delaware, with comparable dismissal or settlement outcomes.
What this case signals for the dental recycling and waste compliance IP landscape
A mutual with-prejudice exit after nearly a year of litigation suggests strategic recalibration — not a clear win for either side.
US11660175B2 survives unchallenged — enforcement risk remains for competitors
Because DRNA’s counterclaims (likely including invalidity) were dismissed with prejudice, no court has ruled on the validity of Solmetex’s detachable recycling container patent. Competitors in the dental amalgam waste space should treat US11660175B2 as an active litigation risk requiring FTO analysis before launching competing products.
No-costs outcome points to negotiated resolution, not capitulation
The symmetric cost arrangement — no award to either party — is a strong indicator of a privately negotiated exit rather than one party conceding defeat. This pattern is common in Delaware District Court when parties reach licensing terms or commercial accommodations they prefer not to disclose in public court filings.
Solmetex v Dental — key questions answered
A with-prejudice dismissal means both parties’ claims are permanently extinguished. Solmetex cannot refile the same infringement claims against DRNA, and DRNA cannot revive its counterclaims. It operates as a final judgment on the merits by operation of law, triggering res judicata as to the specific claims asserted in this Delaware District Court action.
Solmetex asserted US11660175B2 (application US17/965556), a patent covering a detachable recycling container. The product category relates to dental amalgam waste collection and recycling — a compliance-driven market regulated by EPA amalgam rules. The patent has never been the subject of a court-issued claim construction order, meaning its enforceable scope remains judicially untested.
The public record does not disclose the commercial terms behind the dismissal. However, the mutual nature — both claims and counterclaims dismissed with each party bearing its own costs — is consistent with a negotiated resolution such as a licence or market accommodation. Neither side received a cost award, suggesting neither claimed or was recognised as a prevailing party.
No court ruled on the validity of US11660175B2 in this action. DRNA’s counterclaims were dismissed with prejudice, meaning DRNA cannot assert the same invalidity arguments in future litigation against Solmetex. However, the patent’s validity was not adjudicated on the merits, and third parties remain free to challenge it via IPR at the USPTO or in separate litigation.
Solmetex was represented by Ashby & Geddes PC, with counsel including Allison E. Strong, Andrew Colin Mayo, Angelo J. Christopher, and Daniel J. Burnham. Dental Recycling North America was represented by Potter, Anderson & Corroon LLP, with counsel including David Ellis Moore, Andrew Gish, Michael Powell, and Ryan K. Iwahashi. The case was presided over by Judge Maryellen Noreika in the District of Delaware.
PatSnap Eureka searches patents and litigation data to answer instantly.